DLBDolby Laboratories, Inc.
Is the business good?
The checks split: nothing decisive, though earnings fully cash-backed (2.2×).
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
Operating profit is fully backed by cash. Conversion is improving vs a year ago.
Margins have held roughly steady, a stable cost structure.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is DLB?
Dolby Laboratories, Inc. earns 9.9% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.
Return on invested capital · cost of capital 9.0% · 0.87 points above what the capital costs: growth creates value
- Cash conversion
- 2.22×
Cash conversion · 2.00× a year ago · operating cash flow covers the operating profit after tax
- Share count, year on year
- −2.5%
Share count, year on year · bought back, each share owns more of the company
| Year | Operating margin |
|---|---|
| FY2020 | 19% |
| FY2021 | 27% |
| FY2022 | 16% |
| FY2023 | 17% |
| FY2024 | 20% |
| FY2025 | 20% |
Details›
- Free cash flow, trailing twelve months
- $393M
- Net income, trailing twelve months
- $226M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 9.9%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Specialty Business Services
Ranks #8 of 22 by RyuScore